Product
Hib
2 clinical trials
5 indications
Indication
Pneumococcal InfectionsIndication
pneumococcal conjugate vaccineIndication
ApneaIndication
Neonatal ApneaIndication
Premature BirthClinical trial
A PHASE 3 OPEN-LABEL TRIAL TO ASSESS THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN INFANTS AND YOUNG CHILDREN IN CHINA WHO ARE NAIVE TO PNEUMOCOCCAL VACCINATIONStatus: Completed, Estimated PCD: 2021-08-23
Clinical trial
A Prospective, Randomized, Open-label Clinical Trial to Assess Apnea Following Administration of 13-valent Conjugate Pneumococcal Vaccine, Diphtheria Toxoid, Tetanus Toxoid, and Acellular Pertussis Vaccine, Inactivated Polio Vaccine, Hepatitis B Vaccine, and Haemophilus Influenzae Type B Vaccine in Preterm InfantsStatus: Completed, Estimated PCD: 2021-11-01